Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
Dosage Forms: 2 doses of 100 μg each, administered 28 days apart.
Routes of Administration: Intramuscular
Common Trade Names: Moderna<unk>  Moderna<unk>
COVID-19 Vaccine 
Isolation precautions
HIV post-exposure prophylaxis
United States Antibiogram
Vaccination schedule
HIV testing 
Post exposure prophylaxis antibiotics
Crotalidae polyvalent immune Fab 